The use of myocardial and testicular end points as a basis for estimating a proposed tolerable daily intake for sodium monofluoroacetate (1080)

Regulatory Toxicology and Pharmacology

Volumn 47, Issue 1, 2007, Pages 29-36

  Foronda, Natalia M ^a   Fowles, Jefferson ^b   Smith, Nerida ^c   Taylor, Michael ^a   Temple, Wayne ^d   Darlington, Cynthia ^e  

^a MINISTRY OF HEALTH   (New Zealand)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^c GRIFFITH UNIVERSITY   (Australia)

^d National Poisons Centre   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BMDL; Cardiomyopathy; NOAEL; Sodium monofluoroacetate (1080); Testicular effects; Tolerable daily intake (TDI)

Indexed keywords

FLUOROACETATE SODIUM;

ARTICLE; CARDIOTOXICITY; NO OBSERVED ADVERSE EFFECT LEVEL; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; TESTIS; TOLERABLE DAILY INTAKE; TOXICITY TESTING;

ANIMALS; BENCHMARKING; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FLUOROACETATES; FOOD CONTAMINATION; HEART; HUMANS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MYOCARDIUM; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; RODENTICIDES; TESTIS; UNCERTAINTY;

VERTEBRATA;

EID: 33751117804     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2006.08.005     Document Type: Article

References (50)

1. Abernathy, C.H., Donohue, J.M., Cicmanec, J., Poirier, K.A. Reference doses (RfDs): Factors in the selection of human intraspecies uncertainty factor (Ufh) when using human data. Undated report from the 2003 Society of Toxicology meeting, USA.
2. Allen B.C., Kavlock R.J., Kimmel C.A., and Faustman E.M. Dose-response assessments for developmental toxicity: II. Comparison of generic benchmark dose estimates with NOAELs. Fundam. Appl. Toxicol. 23 (1994) 487-495
3. Annison E.F., Hill K.J., Lindsay D.B., and Peters R.A. Fluoroacetate poisoning in sheep. J. Comp. Pathol. 70 (1960) 145-155
4. Baird S.J.S., Cohen J.T., Graham J.D., Shlyakhter A.I., and Evans J.S. Non-cancer risk assessment: a probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 2 (1996) 79-102
5. Barnes D.G., Daston G.P., Evans J.S., Jarabek A.M., Kavlock R.J., Kimmel C.A., Park C., and Spitzer H.L. Benchmark dose workshop: criteria for use of a benchmark dose to estimate a reference dose. Regul. Toxicol. Pharmacol. 21 (1995) 296-306
6. Barnes D.G., and Dourson M. Reference dose (RfD): description and use in health risk assessments. Regul. Toxicol. Pharmacol. 8 (1988) 471-486
7. Beck B.D., Blayton T.M., Calabrese E.J., Baldwin L., and Rudel R. The use of toxicology in the regulatory process. In: Hayes A.W. (Ed). Principles and methods of toxicology. fourth ed. (2001), Taylor and Francis, Philadelphia 23-75
8. Bender J. The use of noncancer endpoints as a basis for establishing a reference concentration for formaldehyde. Regul. Toxicol. Pharmacol. 35 (2002) 23-31
9. Chenoweth M.B. Monofluroacetic acid and related compounds. Pharmacol. Rev. 1 (1949) 383-424
10. Covello V.T., and Merkhofer M.W. Risk Assessment Methods Approaches for Assessing Health and Environmental Risks (1993), Plenum, New York
11. Crump K.S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4 (1984) 854-871
12. Crump K.S. Calculation of benchmark doses from continuous data. Risk Anal. 15 1 (1995) 79-89
13. De Meyer R., and De Plaen J. An approach to the biochemical study of teratogenic substances in isolated rat embryos. Life Sciences 3 (1964) 709-713
14. Department of Conservation and Animal Health Board (DoC and AHB), 2003. The use of 1080 to control possums and other pests: a resource document. Department of Conservation and Animal Health Board, Wellington.
15. Dourson M.L. Methods for establishing oral reference doses (RfDs). In: Mertz W., Abernathy C.O., and Olin S.S. (Eds). Risk Assessment of Essential Elements (1994), ILSI Press, Washington, DC 51-61
16. Dourson M.L., Charnley G., and Scheuplein R. Differential sensitivity of children and adults to chemical toxicity: II. Risk and regulation. Regul. Toxicol. Pharmacol. 35 (2002) 448-467
17. Dourson M.L., Felter S.P., and Robinson D. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 24 (1996) 108-120
18. Eason C.T., Frampton C.M., Henderson R., Thomas M.D., and Morgan D.R. Sodium monofluorocetate and alternative toxins for possum control. N.Z. J. Zool. 20 (1993) 329-334
19. Eason, C.T., Gooneratne, R., Rammell, C.G., 1994. A review of the toxicokinetics and toxicodynamics of sodium monofluoroacetate in animals. In: Seawright, A.A., Eason, C.T. (Eds.), Proceedings of the Science Workshop on 1080. Royal Society of New Zealand Miscellaneous Series 28, pp. 82-89.
20. Eason C.T., and Turck P. A 90-day toxicological evaluation of compound 1080 (sodium monofluoroacetate) in Sprague-Dawley rats. Toxicol. Sci. 69 (2002) 439-447
21. Eason C.T., Wickstrom M., Turck P., and Wright G.R.G. A review of recent regulatory and environmental toxicology studies on 1080: results and implications. N.Z. J. Ecol. 23 2 (1999) 129-137
22. Eisler, R., 1995. Sodium monofluoroacetate (1080) hazards to fish, wildlife, and invertebrates: a synoptic review. US Department of the Interior Biological report 27, 47 p.
23. Fenner-Crisp P. The FQPA 10× safety factor-How much is science? How much is sociology?. Hum. Ecol. Risk Assess. 7 1 (2001) 107-116
24. Foronda N., Fowles J., Smith N., Taylor M., and Temple W. A benchmark dose analysis for sodium monofluoroacetate (1080) using dichotomous toxicity data. Regul. Toxicol. Pharmacol. 47 1 (2006) 84-89
25. Gaylor D.W. Incidence of developmental defects at the no observed adverse effect level (NOAEL). Regul. Toxicol. Pharmacol. 15 (1992) 151-160
26. Gaylor D. Quantalization of continuous data for benchmark dose estimation. Regul. Toxicol. Pharmacol. 24 (1996) 246-250
27. Gaylor D.W., Ryan L., Krewski D., and Zhu Y. Procedures for calculating benchmark doses for health risk assessment. Regul. Toxicol. Pharmacol. 28 (1998) 150-164
28. Hornshaw T.C., Ringer R.K., and Aulerich R.J. Toxicity of sodium monofluoroacetate (Compound 1080) to mink and European ferrets. Environ. Toxicol. Chem. 5 (1986) 213-233
29. International Programme on Chemical Safety (IPCS), 1990. Environmental health criteria 104: Principles for the Toxicological Assessment of Pesticide Residues in Food. Geneva, World Health Organization, International Programme on Chemical Safety.
30. International Programme on Chemical Safety (IPCS), 1992. Chemical Safety. Fundamentals of Applied Toxicology. Geneva, World Health Organization, International Programme on Chemical Safety.
31. International Programme on Chemical Safety (IPCS), 1994. Environmental health criteria 170: Assessing human health risks of chemicals: Derivation of Guidance Values for Health-based Exposure Limits. Geneva, World Health Organization, International Programme on Chemical Safety.
32. International Programme on Chemical Safety (IPCS), 2000. Environmental Health Criteria 214: Human Exposure Assessment. Geneva, World Health Organization, International Programme on Chemical Safety.
33. Kodell R.L., and Gaylor D.W. Combining uncertainty factors in deriving human exposure levels of noncarcinogenic toxicants. Ann. NY Acad. Sci. 895 (1999) 188-195
34. Kroes R. Toxicity testing and human health. In: Van Leeuwen C.J., and Hermens J.L.M. (Eds). Risk Assessment of Chemicals: An Introduction (1995), Kluwer Academic Publishers, Dordrecht 147-174
35. Mazzanti L., Lopez M., and Berte M.G. Atrophy of the testis produced by sodium monofluoroacetate in albino rats. Experientia 21 (1965) 446-447
36. Ministry of Health, 1995. Drinking Water Standards for New Zealand. Ministry of Health, Wellington.
37. Parliamentary Commissioner for the Environment (PCE), 1994. Possum Management in New Zealand. Office of the Parliamentary Commissioner for the Environment, Wellington.
38. Rammell C.G. Persistence of compound 1080 in sheep muscle and liver. Surveillance 20 1 (1993) 20-21
39. Savarie P.J. Toxic characteristics of fluorocitrate, the toxic metabolite of compound 1080. In: Clark D.O. (Ed). Proceedings Eleventh Vertebrate Pest Conference (1984), University of California, Davis 132-137
40. Scheuplein R., Charnley G., and Dourson M. Differential sensitivity of children and adults to chemical toxicity. Regul. Toxicol. Pharmacol. 35 (2002) 429-447
41. Shinoda K., Mitsumori K., Uneyama C., and Uehara M. Induction and inhibition of testicular germ cell apoptosis by fluoroacetate in rats. Arch. Toxicol. 74 (2000) 33-39
42. Smith F.A., Gardner D.E., Yuile C.L., De Lopez O., and Hall L.L. Defluorination of fluoroacetate in the rat. Life Sci. 20 (1977) 1131-1138
43. Sullivan J.L., Smith F.A., and Garman R.H. Effects of fluoroacetate on the testis of the rat. J. Reprod. Fertil. 56 (1979) 201-207
44. Temple W.A., and Edwards I.R. Toxic ducks 1080 residues in game birds. An exercise in applied toxicology. Vet. Hum. Toxicol. 27 (1985) 20-21
45. Twigg L.E., King D.R., and Bradley A.J. The effect of sodium monofluoroacetate on plasma testosterone concentration in Tiliqua rugosa (Gray). Comp. Biochem. Physiol. 91 2 (1988) 343-347
46. U.S. Environmental Protection Agency (U.S. EPA), 1995. The use of the benchmark dose approach in health risk assessment. Office of Research and Development, Washington, DC: EPA/630/R-94/007, February.
47. U.S. Environmental Protection Agency (U.S. EPA), 1996. Pesticides: policy issues related to the Food Quality Protection Act. Fed Reg 64(130), pp. 37001-37009.
48. U.S. Envirnomental Protection Agency (U.S. EPA), 2001. Benchmark dose software, Version 1.3. Available from: .
49. U.S. Environmental Protection Agency (U.S. EPA), 2002. Child-specific exposure factors handbook. National Center for Environmental Assessment, Washington, DC; EPA/600/P-00/002. Available from: National Information service, Springfield, VA, PB2003-101678 and .
50. Whittem J.H., and Murray L.R. The chemistry and pathology of georgina river poisoning. Aust. Vet. J. 39 (1963) 168-173